2021
DOI: 10.1016/j.neurobiolaging.2021.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Genetic epidemiology of familial ALS in Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 21 publications
3
9
0
Order By: Relevance
“…differs from European cohorts (Chadi et al, 2017). This mutation was also found in other studies, including patients from southern Brazil (Nunes Gonçalves et al, 2021;Trilico et al, 2020).…”
supporting
confidence: 77%
See 1 more Smart Citation
“…differs from European cohorts (Chadi et al, 2017). This mutation was also found in other studies, including patients from southern Brazil (Nunes Gonçalves et al, 2021;Trilico et al, 2020).…”
supporting
confidence: 77%
“…The genetic mutation VAPB causes a type of ALS characterized by significant impairment of lower motor neurons, tremors, autonomic dysfunction, and abdominal protrusion, namely, ALS Type 8 (ALS8; Kosac et al, 2013;Nunes Gonçalves et al, 2021;Trilico et al, 2020). As in sALS, cognitive impairments have been observed in patients with ALS8, which include deficits in cognitive flexibility, processing speed, and inhibitory control (de Alcântara et al, 2019(de Alcântara et al, , 2023.…”
mentioning
confidence: 99%
“…Patients with ALS8 have predominant lower motor neuron involvement, with symptoms including progressive muscle weakness (mainly in the lower limbs), muscle atrophy, cramp, tremor, fasciculations, pain, abdominal protrusion, autonomic dysfunction (e.g. choking, constipation), and subtle cognitive and behavioural impairments ( Nishimura et al, 2004a , 2004b ; Marques et al, 2006 ; Funke et al, 2010 ; Kosac et al, 2013 ; Di et al, 2016 ; Chadi et al, 2017 ; Sun et al, 2017 ; Guber et al, 2018 ; de Alcântara et al, 2019 ; Trilico et al, 2020 ; Nunes Gonçalves et al, 2021 ; Temp et al, 2021 ; Leoni et al, 2022 ). ALS8’s clinical heterogeneity manifests not only in the symptoms but also in the age of onset (reported at 20–57 years) and the disease progression (rapid [<5 years] to slow [30+ years]).…”
Section: The Role Of Vapb In Neuronal Disordersmentioning
confidence: 99%
“…This is similar to Japan, where SOD1 mutations are the most common cause of fALS (29.8%), followed by FUS and TARDBP , whereas C9orf72 expansions are rare, identified in only 1.3% of fALS cases [ 56 ]. In Brazil, the most frequent genetic cause is VAPB (30% of all fALS) followed by C9orf72 (22%) [ 57 ].…”
Section: Evs In Alsmentioning
confidence: 99%